
House okays ‘Free OFW Financial Education Act’House okays ‘Free OFW Financial Education Act’ Reina C. Tolentino
||
MANILA, Philippines — The House of Representatives on Tuesday approved on third and final reading the proposed Free OFW Financial Education Act. A total of 179 lawmakers voted for... 
MiTAC Computing Unveils New AI/HPC-Optimized Servers with Advanced CPU and GPU Integration at SC24MiTAC Computing Unveils New AI/HPC-Optimized Servers with Advanced CPU and GPU Integration at SC24 PR Newswire
||
ATLANTA, Nov. 20, 2024 /PRNewswire/ — MiTAC Computing Technology Corporation, an industry-leading server platform design manufacturer and a subsidiary of MiTAC Holdings Corporation (TSE:3706), is unveiling its new server... 
New York Film Academy Ranked #20 in The Wrap’s 2024 Top 50 Film Schools ListNew York Film Academy Ranked #20 in The Wrap’s 2024 Top 50 Film Schools List GlobeNewswire
||
NYFA Students Filming on the Backlot in Los Angeles NYFA students get real world hands-on experiences including an option to shoot on an actual industry Backlot in Los Angeles.... Turpan’s Wind Power Capacity Achieves New Milestone with Over 4 Billion kWh Generated in 2024Turpan’s Wind Power Capacity Achieves New Milestone with Over 4 Billion kWh Generated in 2024 PR Newswire
||
TURPAN, China, Nov. 20, 2024 /PRNewswire/ – As of November 18, 2024, Turpan, a city in China’s Xinjiang region, had generated 4.377 billion kilowatt-hours (kWh) from wind since the... 
Warringtonfire Australia Rebrands to Jensen Hughes, Strengthening Global Fire Safety Engineering, Fire Testing and Fire Assessment ServicesWarringtonfire Australia Rebrands to Jensen Hughes, Strengthening Global Fire Safety Engineering, Fire Testing and Fire Assessment Services PR Newswire
||
Integration expands Jensen Hughes’ fire testing, fire assessment and fire safety engineering expertise across Australia and the Pacific region. SYDNEY, Nov. 20, 2024 /PRNewswire/ — Jensen Hughes, a global... Moatable Reports Third Quarter 2024 Financial ResultsMoatable Reports Third Quarter 2024 Financial Results PR Newswire
||
PHOENIX, Nov. 20, 2024 /PRNewswire/ — Moatable, Inc. (OTC: MTBLY) (“Moatable” or the “Company”), a leading US-based SaaS company, today reported its third quarter 2024 financial results. Third Quarter... 
American Addiction Centers’ “Addiction Talk” Podcast Features Former TV Interventionist Rod Espudo from A&E’s Show “Intervention”American Addiction Centers’ “Addiction Talk” Podcast Features Former TV Interventionist Rod Espudo from A&E’s Show “Intervention” GlobeNewswire
||
NASHVILLE, Tenn., Nov. 19, 2024 (GLOBE NEWSWIRE) — ”Addiction Talk,” the award-winning recovery podcast from American Addiction Centers, recently welcomed Rod Espudo, a former interventionist from A&E’s hit show... 
Swift Navigation and KDDI Launch Skylark Precise Positioning Service Across JapanSwift Navigation and KDDI Launch Skylark Precise Positioning Service Across Japan GlobeNewswire
||
Launch marks milestone in breakthrough partnership to unlock vehicle autonomy and industrial automation with centimeter-accurate positioning KDDI Swift Logos Swift Navigation and KDDI Launch Skylark Precise Positioning Service Across... 
Samsung Biologics signs manufacturing deal with European pharmaceutical companySamsung Biologics signs manufacturing deal with European pharmaceutical company PR Newswire
||
The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics’ cumulative contract value for 2024 surpasses USD 4 billion with latest deals... 
Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis BEpigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B PR Newswire
||
SHANGHAI, Nov. 20, 2024 /PRNewswire/ — Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy, today announced that it has received approval of clinical trial...